Product Development

Innovation Is in Your DNA. It’s in Ours, Too.

Bringing ideas to market

The Alira Health Product Development lab combines scientific expertise with business acumen to guide healthcare innovations from discovery to commercialization.

Working together to transform healthcare

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Contact us
Mitchell Sanders
Mitchell Sanders, PhD
Chief Scientific Officer
Our fully dedicated lab team delivers faster execution and better accountability, accelerating commercialization with major milestones to drive better valuations and ROIs.

Related news

Market Access MedTech
Multimedia February 26, 2021
Pricing in MedTech: Disentangling the Roles of Payers, DRGs, and Procurement
Join host Kenny Carberry, Associate Director of Clinical Development, Dan Legg, former Director of Clinical Sourcing at Guy’s & St Thomas at the St Thomas Hospital in London and CEO(...)
M&A
Publications February 24, 2021
What You Should Know Before Choosing a Healthcare Transaction Advisory Firm
What’s most important when selecting a firm for your next transaction? Global experience, staff profiles, technical expertise? To learn more download our latest TAD Infographic.
MedTech Pharma
Publications February 8, 2021
Infographic: 2021 Trends in Healthcare
It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.
MedTech Pharma
News February 4, 2021
2020 Year in Review
With 2021 in full swing, we want to take a moment to reflect on last year’s achievements and congratulate the entire Alira Health Team for their hard work and dedication to healthcare(...)
Regulatory
News February 2, 2021
We Secured Breakthrough Device Designation from FDA on PEDRA Xauron Perfusion System
We are proud to announce the firm’s Regulatory practice has secured a Breakthrough Device Designation from FDA for the real-time tissue perfusion system, PEDRA Xauron Perfusion System.
Patient Engagement
Publications January 28, 2021
Creating a Lifecycle of Patient Engagement
At Alira Health, we believe the relationship between healthcare companies and patients should be a partnership. Developing this partnership helps build trust, enhances the patient experience,(...)
Patient Engagement
News January 26, 2021
Annabel de Maria Joins Alira Health as Vice President, Patient Engagement
We are pleased to announce that Annabel de Maria has joined the firm as Vice President, Patient Engagement.

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.